Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study

Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study

Bibliographic Details
Main Authors: Girolamo Ranieri, Carmelo Laface, Mariarita Laforgia, Simona De Summa, Mariangela Porcelli, Francesco Macina, Michele Ammendola, Pasquale Molinari, Gianfranco Lauletta, Alessandra Di Palo, Giuseppe Rubini, Cristina Ferrari, Cosmo Damiano Gadaleta
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
tumor angiogenesis
bevacizumab
hyperthermia
chemotherapy
metastatic colon cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.637880/full
id doaj-ea7a808c11b44361947ccbced352073c
record_format Article
spelling doaj-ea7a808c11b44361947ccbced352073c2021-03-05T09:43:06ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011010.3389/fonc.2020.637880637880Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot StudyGirolamo Ranieri0Carmelo Laface1Mariarita Laforgia2Simona De Summa3Mariangela Porcelli4Francesco Macina5Michele Ammendola6Pasquale Molinari7Gianfranco Lauletta8Alessandra Di Palo9Giuseppe Rubini10Cristina Ferrari11Cosmo Damiano Gadaleta12Interventional and Medical Oncology Unit, IRCCS Istituto Tumori “G. Paolo II”, Bari, ItalyInterventional and Medical Oncology Unit, IRCCS Istituto Tumori “G. Paolo II”, Bari, ItalyPharmacy Unit, IRCCS Istituto Tumori “G. Paolo II”, Bari, ItalyMolecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, ItalyInterventional and Medical Oncology Unit, IRCCS Istituto Tumori “G. Paolo II”, Bari, ItalyInterventional and Medical Oncology Unit, IRCCS Istituto Tumori “G. Paolo II”, Bari, ItalyDepartment of Health Science, Digestive Surgery Unit, University “Magna Graecia” Medical School, Germaneto, ItalyInterventional and Medical Oncology Unit, IRCCS Istituto Tumori “G. Paolo II”, Bari, ItalyDepartment of Biomedical Sciences and Human Oncology, Section of Internal Medicine “G. Baccelli”, University of Bari Medical School, Bari, ItalyNuclear Medicine Unit, D.I.M., University of Bari “Aldo Moro”, Bari, ItalyNuclear Medicine Unit, D.I.M., University of Bari “Aldo Moro”, Bari, ItalyNuclear Medicine Unit, D.I.M., University of Bari “Aldo Moro”, Bari, ItalyInterventional and Medical Oncology Unit, IRCCS Istituto Tumori “G. Paolo II”, Bari, Italyhttps://www.frontiersin.org/articles/10.3389/fonc.2020.637880/fulltumor angiogenesisbevacizumabhyperthermiachemotherapymetastatic colon cancer
collection DOAJ
language English
format Article
sources DOAJ
author Girolamo Ranieri
Carmelo Laface
Mariarita Laforgia
Simona De Summa
Mariangela Porcelli
Francesco Macina
Michele Ammendola
Pasquale Molinari
Gianfranco Lauletta
Alessandra Di Palo
Giuseppe Rubini
Cristina Ferrari
Cosmo Damiano Gadaleta
spellingShingle Girolamo Ranieri
Carmelo Laface
Mariarita Laforgia
Simona De Summa
Mariangela Porcelli
Francesco Macina
Michele Ammendola
Pasquale Molinari
Gianfranco Lauletta
Alessandra Di Palo
Giuseppe Rubini
Cristina Ferrari
Cosmo Damiano Gadaleta
Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
Frontiers in Oncology
tumor angiogenesis
bevacizumab
hyperthermia
chemotherapy
metastatic colon cancer
author_facet Girolamo Ranieri
Carmelo Laface
Mariarita Laforgia
Simona De Summa
Mariangela Porcelli
Francesco Macina
Michele Ammendola
Pasquale Molinari
Gianfranco Lauletta
Alessandra Di Palo
Giuseppe Rubini
Cristina Ferrari
Cosmo Damiano Gadaleta
author_sort Girolamo Ranieri
title Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
title_short Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
title_full Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
title_fullStr Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
title_full_unstemmed Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
title_sort corrigendum: bevacizumab plus folfox-4 combined with deep electro-hyperthermia as first-line therapy in metastatic colon cancer: a pilot study
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-02-01
topic tumor angiogenesis
bevacizumab
hyperthermia
chemotherapy
metastatic colon cancer
url https://www.frontiersin.org/articles/10.3389/fonc.2020.637880/full
work_keys_str_mv AT girolamoranieri corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT carmelolaface corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT mariaritalaforgia corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT simonadesumma corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT mariangelaporcelli corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT francescomacina corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT micheleammendola corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT pasqualemolinari corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT gianfrancolauletta corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT alessandradipalo corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT giusepperubini corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT cristinaferrari corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
AT cosmodamianogadaleta corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy
_version_ 1724230733200883712

Similar Items